Last updated on May 2018

Efficacy Safety and Immunogenicity of BI 695501 Versus Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis


Brief description of study

To evaluate the efficacy and to compare efficacy and safety of BI 695501 versus Humira in patients with moderate to severe chronic plaque psoriasis.

Clinical Study Identifier: NCT02850965

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim Call Center

Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia
Gdynia, Poland
0.62miles

Boehringer Ingelheim Call Center

Synexus Polska SCM Sp. z o.o. Gdansku, Gdansk
Gdansk, Poland
7.58miles